Chalmers D T, Lovenberg T W, De Souza E B
Neurocrine Biosciences Inc., San Diego, California 92121, USA.
J Neurosci. 1995 Oct;15(10):6340-50. doi: 10.1523/JNEUROSCI.15-10-06340.1995.
Corticotropin-releasing factor (CRF) is the primary factor involved in controlling the release of ACTH from the anterior pituitary and also acts as a neurotransmitter in a variety of brain systems. The actions of CRF are mediated by G-protein coupled membrane bound receptors and a high affinity CRF receptor, CRF1, has been previously cloned and functionally characterized. We have recently isolated a cDNA encoding a second member of the CRF receptor family, designated CRF2, which displays approximately 70% homology at the nucleotide level to the CRF1 receptor and exhibits a distinctive pharmacological profile. The present study utilized in situ hybridization histochemistry to localize the distribution of CRF2 receptor mRNA in rat brain and pituitary gland and compared this with the distribution of CRF1, receptor expression. While CRF1 receptor expression was very high in neocortical, cerebellar, and sensory relay structures, CRF2 receptor expression was generally confined to subcortical structures. The highest levels of CRF2 receptor mRNA in brain were evident within the lateral septal nucleus, the ventromedial hypothalamic nucleus and the choroid plexus. Moderate levels of CRF2 receptor expression were evident in the olfactory bulb, amygdaloid nuclei, the paraventricular and suraoptic nuclei of the hypothalamus, the inferior colliculus and 5-HT-associated raphe nuclei of the midbrain. CRF2-expressing cells were also evident in the bed nucleus of the stria terminalis, the hippocampal formation and anterior and lateral hypothalmic areas. In addition, CRF2 receptor mRNA was also found in cerebral arterioles throughout the brain. Within the pituitary gland, CRF2 receptor mRNA was detectable only at very low levels in scattered cells while CRF1 receptor mRNA was readily detectable in anterior and intermediate lobes. This heterogeneous distribution of CRF1 and CRF2 receptor mRNA suggests distinctive functional roles for each receptor in CRF-related systems. The CRF1 receptor may be regarded as the primary neuroendocrine pituitary CRF receptor and important in cortical, cerebellar and sensory roles of CRF. The anatomical distribution of CRF2 receptor mRNA indicates a role for this novel receptor in hypothalamic neuroendocrine, autonomic and general behavioral actions of central CRF.
促肾上腺皮质激素释放因子(CRF)是控制促肾上腺皮质激素(ACTH)从垂体前叶释放的主要因子,并且在多种脑系统中作为神经递质发挥作用。CRF的作用由G蛋白偶联膜结合受体介导,一种高亲和力的CRF受体CRF1,先前已被克隆并进行了功能特性分析。我们最近分离出一种编码CRF受体家族第二个成员的cDNA,命名为CRF2,它在核苷酸水平上与CRF1受体显示出约70%的同源性,并表现出独特的药理学特征。本研究利用原位杂交组织化学技术来定位大鼠脑和垂体中CRF2受体mRNA的分布,并将其与CRF1受体表达的分布进行比较。虽然CRF1受体在新皮质、小脑和感觉中继结构中表达非常高,但CRF2受体表达通常局限于皮质下结构。脑中CRF2受体mRNA的最高水平在外侧隔核、腹内侧下丘脑核和脉络丛中明显。CRF2受体表达的中等水平在嗅球、杏仁核、下丘脑的室旁核和视上核、下丘以及中脑5-羟色胺相关的中缝核中明显。表达CRF2的细胞在终纹床核、海马结构以及下丘脑前区和外侧区也很明显。此外,在整个脑的脑小动脉中也发现了CRF2受体mRNA。在垂体中,CRF2受体mRNA仅在散在细胞中以非常低的水平可检测到,而CRF1受体mRNA在前叶和中间叶中很容易检测到。CRF1和CRF2受体mRNA的这种异质性分布表明每个受体在CRF相关系统中具有独特的功能作用。CRF1受体可被视为主要的神经内分泌垂体CRF受体,在CRF的皮质、小脑和感觉作用中很重要。CRF2受体mRNA的解剖学分布表明这种新受体在中枢CRF的下丘脑神经内分泌、自主和一般行为作用中发挥作用。